New software enhances CT image quality across scanner generations, supporting radiologists with improved image clarity and consistencyMENLO PARK, Calif., June 10, 2026 /PRNewswire/ --...
Ally Medical Emergency Room is opening in Magnolia, TX near FM 1488 in 2027 — 24/7 care, board-certified physicians, no wait times for Montgomery County.
Stephen Hahn to Transition to CEO Emeritus and Special Advisor and remain on Harbinger's board
CAMBRIDGE, Mass., Aug. 11, 2025 /PRNewswire/ -- Flagship Pioneering, the...
LOS ANGELES, Aug. 10, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 405 owned and operated outpatient imaging centers, today reported financial results for its second quarter of 2025.
CHICAGO, Aug. 1, 2025 /PRNewswire/ -- Experity, the national leader in on-demand healthcare solutions, today announced the appointment of Bobby Ghoshal as President and Chief...
The certification reinforces the company's leadership in AI safety, efficacy, and ethical governance.
MENLO PARK, Calif., July 30, 2025 /PRNewswire/ -- Subtle Medical, a global...
PARIS, FRANCE, 24 July 2025 - Ipsen announced today that the European Commission has approved Cabometyx® (cabozantinib) for adult patients with unresectable or metastatic, well differentiated pancreatic (pNET) and extra-pancreatic (epNET) neuroendocrine tumors who have progressed following at least one prior systemic therapy other than somatostatin analogues.
Largest commercial insurer in the United States releases positive comprehensive coverage for AI-enabled Heartflow Plaque Analysis to support precise diagnosis and management of patients
Largest commercial insurer in the United States releases positive comprehensive coverage for AI-enabled Heartflow Plaque Analysis to support precise diagnosis and management of patients
With over 80 issued patents and 40 pending patent applications, Autonomix is building a comprehensive IP portfolio in nerve-sensing and modulation, strengthening its strategic position in a multi-billion-dollar market opportunity and unlocking potential across cardiovascular, renal, and other high-burden diseases